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Toxoplasma gondii is an intracellular protozoan parasite that infects roughly one-third 
of the world population. Although infection in healthy individuals is generally 
asymptomatic, it may cause severe health issues in immunocompromised patients. During 
invasion of a mammalian cell, T. gondii establishes a parasitophorous vacuole (PV) which 
is separated from the host cytoplasm by the PV membrane (PVM). The PVM forms a 
critical barrier between T. gondii and the infected cell and is involved in the manipulation 
of host cellular functions, including signaling and nutrient acquisition. Previous 
fluorescence and electron microscopic observations have shown that the parasites are able 
to intercept host Rab trafficking pathways and internalize host Rab vesicles (e.g., Rab11 
vesicles for the recycling pathway) into the PV, but these findings are based on fixed cells. 
What is missing is a dynamic view of the PVM and its interaction with host Rab vesicles 
by live cell imaging. This dynamic view of the PVM will help us to understand the 
mechanism of host vesicle internalization by PVM. Therefore, the aim of this thesis is to 
analyze the dynamics of the PVM over time relative to host Rab vesicles.  
To do so, we selected two PVM proteins, GRA3 and GRA7. We endogenously tagged 
GRA3 and GRA7 with the fluorescent marker mCherry using CRISPR/Cas9 gene editing. 
Both GRA3 and GRA7 are highly expressed and secreted from the parasite’s dense granule 
secretory organelles into the PV where they localize to the PVM and an intravacuolar 
network of membranous tubules (IVN), which has been proposed to be involve in host Rab 
vesicle internalization into the PV. The functional characteristics of GRA3-mCherry and 
GRA7-mCherry expressing strains were evaluated by intracellular growth assays, 
localization assay and live cell imaging. The insertion of mCherry at the 3’ end of GRA3 
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does not interfere with the intracellular replication of the parasite, or the localization of 
GRA3 to the dense granules, PVM and IVN. Though insertion of mCherry at the 3’end of 
GRA7 does not interfere with the growth of the parasite, but it affects the localization of 
GRA7 to the dense granules, PVM and IVN, and it is most likely cleaved from GRA7 
inside the parasite.   
Using the GRA3-mCherry expressing strains, we observed that PVM projections 
(PVMP) are a dynamic feature of the PV, with projections extending into the host cytosol 
and then retracting. To study interactions between host vesicles and the PVM, we infected 
cells stably expressing GFP-Rab11A with GRA3-mCherry expressing parasites and we 
observed that host Rab11A vesicles inside the PV either remained unmoving in the IVN 
region or were transported along the IVN, indicating a role of the IVN in sequestering and 
transporting host vesicles inside the PV. We also observed that host Rab11A vesicles 
contact the PVM, with some vesicles entering the PV, though the moment of entry was not 
captured due to technical complications due to long exposure times leading to fading of the 
GFP signal. The GRA3-mCherry expressing strains generated from our study will also be 
a valuable tool to study various interactions between the PVM and many different host 
organelles, including how PVMPs interact with host organelles. 
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Toxoplasma gondii is an obligate intracellular parasite that infects nearly all warm-
blooded animals and invades any nucleated cells, which makes it as one of the most 
successful and widespread parasites on earth. It has been estimated that Toxoplasma infects 
roughly one-third of the world population, with a prevalence that varies widely from 10% 
to 80% between countries (Robert-Gangneux and Dardé, 2012). Acute infection 
(corresponding to the proliferative phase of the parasite in the small intestine) resulting 
from ingestion of the parasite cysts from contaminated food or water, or infected cat feces 
usually causes no or mild flu-like symptoms, but the parasite forms cysts in various body 
tissues that results in life-long chronic infection. However, although chronic infection with 
T. gondii is generally asymptomatic in healthy individuals, reactivation of the cysts can 
cause devastating ocular, neurological and systemic diseases, most often in 
immunocompromised individuals such as HIV/AIDs patients and in organ transplant 
recipients (Munoz et al., 2010; Wang et al., 2017). In addition, T. gondii can be congenitally 
passed from pregnant women through the placenta to the fetus, resulting in blindness, 
cognitive impairment, hydrocephalus or abortion (Mastroiacovo & Torgerson, 2013).  
Current therapy for Toxoplasma infection only controls acute infections and is 
associated with adverse reactions. For example, it is recommended to treat toxoplasmosis 
using a combination of pyrimethamine and sulfadiazine which inhibit parasite folate 
metabolism (Rajapakse et al., 2013). However, pyrimethamine and sulfadiazine have 
significant adverse effects by decreasing red blood cells, white blood cells and platelets 
(Neville et al., 2015; Montazeri et al., 2017). There currently is no drug to clear the chronic 
cyst form and no vaccine to prevent T. gondii infections. Due to the high prevalence and 
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life-long threat of T. gondii infection, new strategies and therapeutic drugs are needed to 
prevent and treat both T. gondii acute and chronic infections. 
A.  Life cycle and transmission of T. gondii 
T. gondii has a complex life cycle with a sexual cycle in the definitive host (felids), 
and an asexual cycle in intermediate hosts (warm-blooded animals) (Figure 1). In the 
sexual cycle, a cat (domestic and wild) ingests tissue cysts from the skeletal muscle, heart 
and brains of an infected intermediate host. The tissue cyst wall is dissolved by proteolytic 
enzymes in the cat’s stomach and small intestine, releasing bradyzoites from the cyst that 
infect the epithelial cells of the cat’s small intestine. The bradyzoites invade epithelial cells 
and differentiate into merozoites, reproduce rapidly and give rise to male and female 
gametes, which fuse together to form a zygote and mature as an oocyst (Ferguson, 2004). 
The oocyst is passed through cat feces and sporulates in the environment to become highly 
infectious. It can be widely spread to contaminate water, soil, or food, and can survive in 
old and dry environment for years (Dubey et al., 2011). In intermediate hosts (all warm-
blooded animals), T. gondii oocysts or tissue cysts release sporozoites and bradyzoites, 
respectively, which infect intestinal epithelial cells. The parasites convert to the fast-
growing tachyzoite form that disseminates throughout the body. Due to pressure from the 
host immune responses to infection, tachyzoites convert to bradyzoites and form tissue 
cysts (Miller et al., 2009). These cysts can be found in various tissues inside host body, 
predominantly in skeletal muscle, heart, brain and eye tissues (Kim & Weiss, 2011).  
Consumption of undercooked meat with tissue cysts is one of the major ways of T. 
gondii infection, both in human and meat-eating animals, as well as ingestion of oocyst- 
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contaminated water, soil, or food. In fact, Toxoplasma is a major cause of food-borne 
illness (Hussain et al., 2017). Humans can also pick up oocysts from the litter boxes of 
infected indoor or outdoor cats. Therefore, pregnant women are advised not to clean cat 
litter boxes during the pregnancy as a prevention of T. gondii infection. In the United States, 
oocysts are the major source of congenitally transmitted T. gondii infection, which leads to 
severe health consequences for the fetus (Boyer et al., 2011).  
 
Figure 1-Transmission of T. gondii in intermediate and definitive hosts. Felidae such 
as cats are the only known definitive hosts for T. gondii, who shed highly infectious oocysts 
in the environment. Humans can be infected by T. gondii by ingesting oocysts from 
infected cat, contaminated food and water, and eating poorly cooked meat with tissue cysts. 
In some rare cases, T. gondii is transmitted through organ transplantation. In pregnant 





B.  Intracellular invasion of T. gondii 
Host cell invasion is essential for T. gondii as a survival strategy because it is an 
obligate intracellular parasite (Kafsack et al., 2009). There are multiple steps for host cell 
invasion by T. gondii (Figure 2).  
When T. gondii infects a host cell, it first attaches, using its apical end, to the host cell 
plasma membrane. The apical end contains secretory organelles, such as micronemes and 
rhoptries, that secretes parasite proteins, such as apical membrane antigen 1 (AMA1) and 
rhoptry-derived proteins 2 (RON2), to create a ring like moving junction (Tonkin et al., 
2011). The moving junction mediates the invagination of the host cell plasma membrane, 
which surrounds the parasites to form a parasitophorous vacuole (PV), and it excludes 
transmembrane host proteins from the PV membrane (PVM) but contains many proteins 
secreted by the parasite, creating a unique niche for the parasite inside the host cytosol 
(Sibley et al., 1999; Sibley and Charron, 2004). The PVM does not fuse with any host 
organelles (non-fusogenic) and forms a critical barrier between T. gondii and the host 
cytoplasm, protecting parasites from host attack mechanisms. For example, studies have 
shown that the PVM, lacking host endocytic markers, helps protect the PV from fusion and 
destruction by host lysosomes (Mordue et al., 1999). The PVM is also involved in 
manipulation of host cellular functions, such as NF-kB signaling and nutrient acquisition 
(Molestina et al., 2003; Sinai et al.,2007), but the molecular players of these manipulations 
remain largely unknown. 
After invasion of the host cell, the PVM interacts and associates with several host 
organelles, including the endoplasmic reticulum (ER), microtubules, Golgi and 
mitochondria (de Melo et al., 1992; Walker et al., 2008; Romano et al., 2013). The parasite 
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replicates asexually by endodyogeny around every eight hours. In the process of 
endodyogeny, two daughter cells are formed within the mother cell, which is consumed by 
the daughters before their separation. This process continues until the host cell is filled with 
parasites (Blader et al., 2015).  
Parasites then egress from the host cell after the breakdown of the host cell plasma 
membrane in response to K+ and Ca+ ion fluxes (Kafsack et al., 2009). Indeed, previous 
studies have shown that the mechanical pressure of the PV leads to an ionic imbalance, 
which triggers the egress of T. gondii (Moundy et al., 2001). In response to the ion 
imbalance, the parasites secrete perforins that permeabilize the PVM (Kafsack et al., 2009). 
The Toxoplasma Ca2+-dependent protein kinase 3 (TgCDP3), which responds to 
cytoplasmic Ca2+ ions, is also important to regulate egress through the phosphorylation of 
the parasite’s actin-myosin motor leading to the activation of parasite motility for 




Figure 2-Intracelullar parasitism of T. gondii. ①attachment to the host cell plasma membrane. ② secretion of Toxoplasma proteins 
to make a moving junction. ③Invagination of host plasma membrane and creation of PVM (dark green) during invasion. ④ 
Formation of PV, which associates with host organelles such as mitochondria and ER. ⑤ Replication of T. gondii inside the PV by 
endodyogeny. ⑥ Egress of T. gondii from the PV and the host cell.
7 
 
C.  Scavenging of host nutrients 
As an obligate intracellular parasite, T. gondii needs to rely on its host for nutrients to 
survive and replicate. Essential nutrients for T. gondii include tryptophan (Pfefferkorn, 
1984), arginine (Fox et al., 2004), polyamines (Seabra et al., 2004), purines (Schwartzman 
and Pfefferkorn, 1982), cholesterol (Coppens and Joiner, 2003), iron (Dimier and Bout, 
1998) and other lipids (Sibley and Charron, 2002). Though the PVM provides a protective 
barrier for T. gondii, its non-fusogenic property also poses a challenge for the parasite to 
get access of nutrients from the host. At least, the PVM has small pores that allows small 
solutes less than 3kDa, such as NTPs, glucose, amino acids, to passively diffuse into the 
PV (Schwab et al., 1994; Gold et al., 2015). To obtain nutrients for host organelles, T. 
gondii has adopted a unique strategy: association of host organelles with the PVM followed 
by their sequestration into the PV lumen (Coppens, 2014).  
Host mitochondria are a site of lipid metabolism, which may provide molecules such 
as ATP and lipids for T. gondii (Coppens, 2014). In fact, T. gondii scavenges lipoate from 
host mitochondria (Crawford et al, 2006). The host Golgi provide sphingolipids and studies 
have shown that the growth of T. gondii is decreased in cells impaired for sphingolipid 
production (Pratt et al., 2013; Romano et al., 2013). The host microtubular network plays 
an important role in the movement of membrane-bound compartments such as endosomes 
and lysosomes (Coppens et al., 2006). To recruit host endocytic compartments and Golgi 
vesicles, T. gondii reorganizes the microtubular network around the PV by associating with 
the microtubule-organizing center (MTOC) and the Golgi. Sphingolipids produced in the 
host Golgi and LDL cholesterol in host endolysosomes are transported to the PV (de Melo 
and De Souza, 1996; Coppens et al., 2000; Romano et al., 2013). Previous evidence from 
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the Coppens lab has shown that the parasite is able to intercept host Rab trafficking 
pathways and internalize host Golgi Rab vesicles into the PV (Figure 3) to acquire 
sphingolipids (Romano et al., 2017; Romano et al., 2013), but the molecular mechanisms 
of host vesicle internalization into the PV remains unknown. The PVM is hypothesized to 
play a role in these functions; indeed, this membrane forms long tubule extensions upon to 
50 µm that pervade the host cytosol and contact host organelles (Dubremetz et al., 1993; 
Jacobs et al., 1998; Rome et al., 2008; Coppens et al., 2006; Romano et al., 2013; Romano 
et al., 2017). Within the PV lumen, membranous tubules initially secreted by the parasite 
form an entangled network, named the intravacuolar network (IVN) as shown in Figure 4 
(Sibley et al., 1995). Some of these IVN tubules attach to the PVM and contain host 
organelles in their lumen, suggesting that the PVM and IVN contribute to the 
internalization of host organelles within the PV by forming conduits; in fact, parasite 
mutants defective in the IVN internalize fewer host organelles (Romano et al., 2017). These 
findings are based on fixed cells analyzed by immunofluorescence and electron microscopy. 
What is missing is a dynamic view of the PVM and its interaction with host Rab vesicles 
by live cell imaging. The activities at the PVM are likely plastic, reflecting temporal 





Figure 3-Attraction and sequestration of host Rab1 vesicles into the PV of Toxoplasma. 
Rab1 vesicles shuttle between the ER and the cis-Golgi and localize to these compartments 
in uninfected cells as seen in mammalian cells expressing GFP-Rab1. Upon infection, 
GFP-Rab1 vesicles concentrate around the PV (orange arrow) and are trapped inside the 





Figure 4-Role of the IVN in host organelle sequestration into the PV of Toxoplasma. 
A-B. Transmission EM showing the IVN labeled with an asterisk (Romano et al., 2017). 
P, parasite; hc, host cell. C. Scanning EM of the PV showing the IVN (white arrow) and a 
tubule of the IVN (yellow arrow) attached to the PVM (Magno et al., 2005). D.  IFA of 
infected cells expressing GFP-Rab11, showing Rab11 vesicles concentrated to the IVN. 
(Romano et al., 2017) E. Transmission EM of mammalian cells incubated with LDL-gold 
particles to label endocytic organelles. LDL-containing organelles are seen inside a tubule 





D.  Dense granule proteins 
T. gondii contains secretory organelles called dense granules that secrete proteins 
(GRA) into the PV. (Carruthers and Sibley, 1997). These proteins are important for 
maintaining the PV environment for T. gondii intracellular survival and replication (Nam, 
2009). Some GRA proteins are able to traffic beyond the PV into the host cytoplasm or 
nucleus, and interfere with host cell signaling pathways and gene expression. For example, 
GRA15 activates the NF-kB pathway, which induces IL-12 production (Rosowski et al., 
2011). GRA6 manipulates host immune responses by activating NFAT4, the host 
transcription nuclear factors of activated T cells 4 (Ma et al., 2014).  
Inside the PV, some soluble GRAs localize to the PV lumen, and membrane-
associated GRAs traffic to the PVM or IVN (Rome et al., 2008). For example, GRA1 is 
secreted within the vacuolar space of the PV. Vaccine studies indicate that GRA1 is a 
promising immunogenic candidate because it can induce an immunodominant response 
(Beghetto et al., 2001). Gene knockout studies have shown that GRA2 and GRA6 localize 
to the IVN, and are essential for IVN biogenesis (Mercier et al., 2002). Many membrane-
associated GRA proteins are type 1 transmembrane proteins that traffic to the PVM (shown 
in Figure 5), and can contact both the vacuolar space of the PV and the host cytoplasm 










Figure 5-Localization of GRAs in T. gondii PV and host cells. GRAs are secreted from 
dense granules inside the parasite, and localize to the IVN (GRA 2,4,6,7,9,12), vacuolar 
space (GRA1,16,24), PVM (GRA3,5,6,8,10,14,15,22,24,40) and host nucleus 








E.  Gene editing of T. gondii 
 Clustered regularly interspaced short palindromic repeats (CRISPR) together with the 
Cas 9 enzyme form a naturally occurring system that is used as a defense mechanism in 
bacteria and archaea (Barrangou et al., 2007). Since its discovery, the CRISPR/Cas9 
system has been widely adapted for editing genes in many organisms. This system is very 
efficient for targeted gene disruption and site-specific insertion through homologous 
recombination (Shen et al., 2014). In the CRISPR/Cas9 system, Cas9 nuclease is guided 
by a single guide RNA (sgRNA) targeting a specific site in the genome. It binds to the 
Protospacer adjacent motif (PAM) sequence, which follows the targeting site, and 
generates a double strand break (DSB) in the targeting site. Subsequently, cellular 
pathways are activated to repair the DSB, including non-homologous end joining (NHEJ), 
homologous repair (HR), or other alternative repair pathways (Figure 6; Cribbs and Perera, 
2017). The CRISPR/Cas system has been used to efficiently mediate gene editing of T. 
gondii, including gene disruption (Bai et al., 2018; Wang et al., 2016) and complementation 

















Figure 6-Mechanisms of CRISPR-Cas9 mediated gene editing. sgRNA recognizes a 
specific site in the genome, which recruits the Cas9 endonuclease. Binding of Cas9 
endonuclease introduce a DBS, which is repaired by subsequent cellular repair including 
non-homologous end joining (NHEJ) or homology directed repair (HDR). Taken from 





F.  Study goal 
Previously it was shown that T. gondii intercepts host Rab trafficking pathways and 
internalizes host Rab vesicles into the PV (Figure 3). As the PVM is non-fusogenic, but 
host vesicles are observed inside the PV, the mechanism of entry of host vesicles into the 
PV is enigmatic. EM observations suggest that IVN tubules are involved in vesicle 
internalization by attaching to the PVM and forming conduits. To further explore this 
possible scenario, we need a dynamic view to of the interactions between host vesicles and 
the PVM.  
In the present study, we thus explored the interactions between host vesicles and PVM 
through live cell imaging. To achieve this goal, we adopted the CRISPR/Cas9 system to 
engineer Toxoplasma strains that stably express a mCherry-labeled dense granule protein, 
GRA3 or GRA7. These two proteins are highly expressed and localize to the PVM and 
IVN.  I used these strains for live cell imaging to observe the interaction between host GFP-
Rab11 vesicles and the PVM. Those parasite strains will also be valuable as a tool to study 


















2.  MATERIAL AND METHODS: 
A. Reagents and antibodies  
All reagents were purchased from Sigma (St. Louis, MO) or Thermo Fisher Scientific 
(Waltham, MA), unless otherwise stated. The primary antibodies used for 
immunofluorescence assays (IFA) were monoclonal mouse anti-GRA3 provided by J.F. 
Dubremetz (Université of Montpellier, Montpellier, France) and polyclonal rabbit anti-
GRA7 (Coppens et al., 2006). Secondary antibodies used were anti-mouse and anti-rabbit 
conjugated to Alexa Fluor 488 (Invitrogen, Carlsbad, CA). The primary antibodies used 
for western blot analysis were monoclonal mouse anti-GRA3, rabbit polyclonal anti-GRA7 
and polyclonal rabbit anti-DsRed (Takara Bio, Mountain View, CA). The secondary 
antibodies used were horseradish peroxidase-conjugated goat anti-mouse and donkey anti-
rabbit IgG (GE Health Care, UK). 
B. Mammalian cell and parasite cultures 
Human foreskin fibroblasts (HFF) were purchased from the American Type Culture 
Collection (Manassas, VA) and grown as monolayers. VERO cells stably expressing GFP-
Rab11A were generated previously (Romano et al., 2017). All cells were maintained at 
37°C in 5% CO2 and cultivated in alpha-minimum essential medium (Alpha MEM) 
supplemented with 10% fetal bovine serum (FBS), 2mM glutamine, and 
penicillin/streptomycin (100 units/ml per 100 μg/ml). The tachyzoite form of Toxoplasma 
strain RH was used throughout this study including: ΔKu80Δhxgprt (Huynh and Carruthers, 
2009), GRA3-mCherry and GRA7-mCherry.The parasites were propagated in vitro through 
serial passage in HFF monolayers (Khan and Grigg, 2017). 
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C. Construction of Plasmids 
All plasmids, primers and sgRNAs used in this study are listed in Table I. We used 
CRISPR/Cas9 gene editing to tag GRA3 or GRA7 in the genome with mCherry. Guide 
RNA (gRNA) of GRA3 or GRA7 was designed using two websites, Eukaryotic Pathogen 
CRISPR guide RNA/DNA Design Tool (http://grna.ctegd.uga.edu/) and E-CRISPR 
(http://www.e-crisp.org/E-CRISP/).  The GRA3 or GRA7 gRNA was engineered into 
plasmid pSAG1::CAS9-U6::sgUPRT (Shen et al., 2017) to replace UPRT sgRNA by using 
the Q5 Mutagenesis Kit (NEB, Ipswich, MA), and to generate pSAG1::CAS9-
U6::sgGRA3 or pSAG1::CAS9-U6::sgGRA7 (Figure 7). Positive plasmids were extracted 
with the QIAprep Spin Miniprep Kit (Hilden, Germany) and confirmed by DNA 
sequencing. 
To generate the GRA3-mCherry targeting plasmid, the pminiHXGPRT plasmid 
(Donald et al., 1996) was used as the backbone. GRA3 from plasmid pTUB-GRA3-YFP 
(unpublished plasmid created previously in the laboratory), mCherry from plasmid 
pmCherry-Cl (Takara Bio, Japan), DHFR 3’UTR from pminiHXGPRT and GRA3’3UTR 
from genomic DNA of RH strain were amplified by PCR using the Expand High Fidelity 
PCR kit (Roche, Switzerland); primers used for PCR were shown in Table II. The PCR 
products were assembled into the pminiHXGPRT using the HIFI assembly Kit (NEB, 
Ipswich, MA) to generate the targeting plasmid, GRA3-mCherry-HXGPRT-GRA3 3’UTR 
(Figure 8). Positive plasmids were screened for by colony PCR, extracted with QIAprep 
Spin Miniprep Ki and confirmed by sequencing. The same method was used to create the 
GRA7-mCherry targeting plasmid, GRA7-mCherry-HXGPRT-GRA7 3’UTR. Both 





















Figure 7-Creation of mutagenized CRISPR/Cas9 plasmids. 
UPRT gRNA on pSAG1::CAS9-U6::SGUPRT plasmid was 
replaced by either GRA3 gRNA or GRA7 gRNA sequences with 
Q5 mutagenesis kit.  The new mutagenized plasmids were 












Figure 8- Construction of targeting plasmids. GRA3 or GRA7, mCherry, 
DHFR’3UTR and GRA3 or GRA7 3’UTR were assembled into a 
pminiHXGPRT plasmid by HIFI assembly kit. Sequences were confirmed by 
colony PCRs, enzyme digestion, gel electrophoresis, and sequencing. 
Targeting constructs (GRA3-mCherry-HXGPRT-3’UTR and GRA7-
mCherry-HXGPRT-3’UTR) were digested for transfection into Toxoplasma.  
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Ipswich, MA), extracted with a QIAquick Gel Extraction Kit (Hilden, Germany) and 
confirmed by DNA sequencing.  
D. Generation of GRA3-mCherry and GRA7-mCherry strains  
To generate GRA3-mCherry or GRA7-mCherry parasite strains, freshly egressed 
ΔKu80Δhxgprt parasites were collected, pelleted and resuspended in Cytomix buffer (2mM 
EDTA,120mM KCL, 0.15mM CaCl2, 10mM K2HPO4/KH2PO4, 25mM HEPES, 5mM 
MgCl2.6H2O; pH7.6). ΔKu80Δhxgprt parasites were transfected by electroporation (setting: 
1.5KV, 25Ohms resistance, 25µF capacitance, time constant of 0.3-0.7μs) with CRISPR 
plasmids (30µg) containing either GRA3 gRNA or GRA7 gRNA and the corresponding 
digested targeting plasmids (30µg). After overnight incubation with HFF cells, 
transfectants were placed under selection with 25µg/ml mycophenolic acid, 59µg/ml 
xanthine and 0.1N HCl. After 2-3 days of drug selection, transfectants were plated for 
single clones in 96-well plates. Individual clones were screened for GRA3-mCherry or 
GRA7-mCherry signal using a Nikon T200 microscope equipped with a 40X objective. 
For each strain, two single clonal populations were obtained.  
E. Confirmation of mCherry insertion into the parasite genome 
To confirm if the inserted targeting construct is in the correct location in the genome 
of GRA3-mCherry and GRA7-mCherry strains, PCR was carried out using Expand High 
Fidelity PCR kit (Roche, Switzerland). Primers used for PCR were designed using NCBI 
Primer Designing Tool (https://www.ncbi.nlm.nih.gov/tools/primer-blast/). All primers 
used are listed in Table II. Primers outside GRA3 or GRA7 and within the mCherry 
sequence region were used to detect the insertion of mCherry at the 3’end of GRA3 or 
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GRA7. Primers within the HXGPRT and outside the 3’UTR of GRA3 or GRA7 were used 
to detect the presence of HXGPRT. Genomic DNA of GRA3-mCherry, GRA7-mCherry and 
parental strains were extracted using GenElute Mammalian Genomic DNA Miniprep Kit.  
PCR amplification was in a 0.2ml PCR tube consisting 50uL of PCR reaction mixture 
(150ng DNA template, 1X expand buffer with 15mM MgCl2, 200µM dNTPs, 300nM of 
primers, 0.75µl High Fidelity enzyme and H2O) and was run on a C1000 Touch Thermal 
Cycler (Bio-Rad Laboratories, Hercules, CA). The thermal cycle was programmed for 2 
min at 94 °C for initial denaturation, followed by 10 cycles of 15 s at 94 °C for denaturation, 
30 s at corresponding Tm for annealing, 2.5 min at 72 °C for extension, Then the thermal 
cycle started another 20 cycles (+5 s/cycle) of 15 s at 94°C for denaturation, 30 s at 
corresponding Tm for annealing, 2.5 min at 72 °C for extension, and ended with 7 min at 
72 °C for the final extension. PCR products and the size marker (1 kb DNA ladder; New 
England Biolabs, Ipswich, MA) were separated by electrophoresis at 75 V for 1.5 hours in 
a 1% agarose gel in 1 x TBE buffer (10.8g Tris,5.5g Boric acid, and 0.5M Na2EDTA in 
H2O). The electrophoresis gel was soaked in 0.5µg/ml ethidium bromide for 20 minutes 
and then examined in UV light.  
F. Plaque assays 
HFF cells were grown in 6-well plates until confluent. Freshly egressed GRA3-
mCherry, GRA7-mCherry and ΔKu80Δhxgprt parasites were counted with a 
hemocytometer and 100 parasites were added per well of 6-well plates. The plates were 
incubated at 37°C in 5% CO2 for 6 days. The cells were then fixed in 100% of ethanol for  
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5 min and stained in a crystal violet solution (1% of ammonium oxalate and 10% of crystal 
violet in 100% ethanol) for 5 min.  The plates were scanned using a ScanWizard 5 scanner 
(Microtek, Santa Fe Springs, CA). The area of each plaque was measured using Volocity 
software (PerkinElmer, Waltham, MA) using an ROI tool. The mean area and SD of the 
plaques were calculated from three independent experiments, and p values were calculated 
using the paired T test in Prism GraphPad (La Jolla, CA). 
G. Immunoblotting 
Freshly egressed parasites of GRA3-mCherry, GRA7-mCherry and ΔKu80Δhxgprt 
strains were collected from one well of a 6-well plate, pelleted and washed with 1ml of 1X 
PBS. Parasites were then resuspended into 24μl RIPA butter (10mM Tris-Cl, 1mM EDTA, 
1% Triton X-100, 0.1% C24H39NaO4, 0.1% SDS, 140mM NaCl and 1mM PMSF), 6ul 5X 
sample buffer (0.25M Tris-HCl, 0.5M DTT, 10% SDS, 50% glycerol, 0.5% Bromophenol 
Blue) and 0.6μl Beta-mercaptoethanol and boiled for 5 min. Cell lysates (10µl) were 
separated by SDS-PAGE and transferred to a polyvinylidene fluoride (PVDF) membrane 
(Millipore, Bedford, MA). The membrane was blocked in blocking buffer (10% milk in 
1X PBS) for 60 min, and then incubated with either mouse anti-GRA3 (1:8000), or rabbit 
anti-GRA7 (1:5000) antibodies for 60 min, or rabbit anti-DsRed in 5% milk/PBST(1X PBS 
and 0.1% Tween 20) for overnight. The membrane was then washed with PBST for three 
5-min washes. Next, the membrane was incubated with horseradish peroxidase-conjugated 
donkey anti-rabbit IgG antibody or goat anti-mouse IgG antibody (1:10,000 in 5% 
milk/PBST) for 1 hour, followed by three 5-min washes before detection by 




H. Immunofluorescence and fixed cell microscopy 
To perform immunofluorescence assays (IFA), strains of freshly egressed Toxoplasma 
were used to infect HFFs grown on coverslips for 30 min, followed by cascade washes 
with 1X PBS to remove non-evading extracellular parasites. After a 20-hour incubation, 
coverslips were fixed with fixative solution (4% formaldehyde and 0.02% glutaraldehyde 
in PBS) for 15 min, washed with PBS and permeabilized with 0.3% Triton X-100/PBS for 
5 min. The coverslips were then washed with 1X PBS and blocked in blocking buffer (3% 
BSA/PBS) for 1 hour, followed by incubation in primary antibody diluted 1:600 in 
3%BSA/PBS for 1 hour and later three 5-min PBS washes. The samples were incubated 
with secondary antibody diluted 1:2000 in 3% BSA/PBS for 1 hour, followed by three 5-
min PBS washes. Nucleus of HFF and Toxoplasma was detected by incubating coverslips 
in 1mg/ml DAPI diluted 1:1000 in PBS for 5 min. Coverslips were mounted with ProLong 
Diamond Antifade Mountant (Life Technologies, Carlsbad, CA).  Cells were viewed with 
a Zeiss AxioImager M2 fluorescence microscope equipped with an oil-immersion Zeiss 
plan Apo 100x/NA 1.4 objective and a Hamamatsu ORCA-R2 camera. Optical z-sections 
with 0.2µm spacing were acquired using Volocity 6.3.1 acquisition module (Perkin Elmer, 








I. Live cell imaging  
HFF or VERO cells stably expressing GFP-Rab11A were plated into wells of a 24-
well microscopy plate (ibidi GmbH, Martinsried, Germany) and infected with freshly 
egressed GRA3-mCherry expressing parasites for 24 hours. Cells were viewed using a 
DeltaVision RT microscope system (Applied Precision, Issaquah, WA) equipped with a 
60x oil immersion objective (NA 1.42), a humidified chamber with temperature (37°C) 
and CO2 (5%) control, and a Scientific CMOS camera. Live time-lapse images were 
captured as z-stacks with a step size of 0.2µm and deconvolved (Softworx, Applied 
Precision). Image analysis and preparation was performed using Fiji Image J (Schindelin 
et al., 2012).  
J. Image Analysis 
For intracellular growth assay, 100 of PV were randomly chosen for each strain. The 
mean area and SD of the parasite per PV were calculated from three independent 
experiments, and p values were calculated using the paired T test in Prism GraphPad. 
Images from fixed cell microscopy were deconvolved with an iterative restoration 
algorithm using calculated point spread functions, adjusted brightness and contrast, and 
cropped through Volocity software. To measure the level of colocalization using Volocity, 
Pearson’s correlation coefficients (PCCs) were calculated along with a positive product of 
the difference of the means (PDM). 
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Plasmid Used for 
pSAG1::CAS9-U6::sgUPRT Constructing mutagenized CRISPR/Cas9 plasmids targeting 
GRA3 gRNA or GRA7 gRNA 
pSAG1::CAS9-U6::GRA3 gRNA CRISPR plasmid targeting GRA3 gRNA 
pSAG1::CAS9-U6::GRA7 gRNA CRISPR plasmid targeting GRA7 gRNA 
pTUB-GRA3-YFP Amplifying GRA3 
pmCherry-C1 Amplifying mCherry 
pminiHXGPRT Constructing targeting constructs 
GRA3-mCherry-HXGPRT-GRA3 3’UTR Generating GRA3-mCherry Toxoplasma strain 
GRA7-mCherry-HXGPRT-GRA7 3’UTR Generating GRA7-mCherry Toxoplasma strain 
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Primer Sequence Used for 




oJR110 GGAACAAAAGCTGGTACCATGGACCGTACCATATGTC Forward primer to amplify GRA3 
from plasmid pTUB GRA3-YFP 
oJR111 ATGGGCCCTTTCTTGGAGGCTTTGTC Reverse primer to amplify GRA3 
from plasmid pTUB-GRA3-YFP 
oJR112 TCCAAGAAAGGGCCCATGGTGAGCAAGGGCGAGG Forward primer to amplify mCherry 
from plasmid pmCherry-C1 for 
making GRA3-mCherry-HXGPRT-
GRA3 3’UTR plasmid 
oJR113 TCGATACCGTCGACCTCGAGCTACTTGTACAGCTCGTCCATG Reverse primer to amplify mCherry 
from plasmid pmCherry-C1 for 
making GRA3-mCherry-HXGPRT-
GRA3 3’UTR plasmid 
oJR114 TTCATGAGTTGTTTTAGAGCTAGAAATAGC  Forward primer to replace sg UPRT 
to GRA3 gRNA in plasmid 
pSAG1::CAS9-U6::sgUPRT 
oJR115 GGGTTGCCTCAACTTGACATCCCCATTTAC  Reverse primer to replace sg 
UPRT to GRA3 gRNA in plasmid 
pSAG1::CAS9-U6::sgUPRT 
oJR122 GGCGAAGATGGTTTTAGAGCTAGAAATAGC Forward primer to replace sg UPRT 




oJR123 TGATTCAGGCAACTTGACATCCCCATTTAC Reverse primer to replace sg UPRT 




Forward primer to amplify GRA7 
3'UTR from Toxoplasma genomic 
DNA; also used for colony PCR to 




Reverse primer to amplify GRA7 
3'UTR from Toxoplasma genomic 
DNA; also used for colony PCR to 




Forward primer to amplify GRA7 
from Toxoplasma genomic DNA; 
also used for colony PCR to confirm 
the presence of GRA7 
oJR131 CCTTGCTCACCATGGGCCCCTGGCGGGCATC  Reverse primer to amplify GRA7 
from Toxoplasma genomic DNA; 
also used for colony PCR to confirm 
the presence of GRA7 
oJR132 CCGCCAGGGGCCCATGGTGAGCAAGGGCGAG  Forward primer to amplify mCherry 
from pmCherry-C1 to create GRA7-
mCherry-HXGPRT-GRA7 3'UTR 
oJR133 CAGCTTCTGTGGGCTCGAGCTACTTGTACAGCTC  Reverse primer to amplify mCherry 
from pmCherry-C1 to create GRA7-
mCherry-HXGPRT-GRA7 3'UTR 
oJR134 CAAGTAGCTCGAGCCCACAGAAGCTGCCCGT  Forward primer to amplify DHFR 
3’UTR from pmini-HXGPRT 






Reverse primer to amplify DHFR 
3’UTR from pmini-HXGPRT 
plasmid to create GRA7-mCherry-
HXGPRT-GRA7 3'UTR; also used 
as the reverse primer to amplify 
DHFR 3’UTR to create GRA3-
mCherry-HXGPRT-GRA3 3'UTR 
and colony confirmation 
oJR136 GGACGAGCTGTACAAGTAGCTCGAGACCCTGCATAGCCCACAG Forward primer to amplify DHFR 
3’UTR from pmini-HXGPRT 
plasmid to create GRA3-mCherry-




Forward primer to amplify GRA3 
3’UTR from Toxoplasma genomic 
DNA to create GRA3-mCherry-
HXGPRT-GRA3 3'UTR; also used 
for colony PCR to confirm the 
presence of GRA3 3’UTR 
oJR138 CCACCGCGGTGGCGGCCGCTCTAGATTTGCGCGATGTCGATGT
AC 
Forward primer to amplify GRA3 
3’UTR from Toxoplasma genomic 
DNA; also used for colony PCR to 




oJR139 GCTCACGCAGAGGCAATACT  Forward primer to amplify 
GRA3 to mCherry in the 
genome of GRA3-mCherry 
strain; test location in genome 
oJR140 TGGCCTTGTAGGTGGTCTTG  Reverse primer to amplify 
GRA3 to mCherry in the 
genome of GRA3-mCherry 
strain; test location in genome 
oJR141 CGGTCCCAAGTCGATGAGAAT  Forward primer to amplify 
HXGPRT to GRA3 3' UTR; test 
whether GRA3-mCherry was 
inserted in the correct location 
in the genome 
oJR142 CGCGTCGAGTAACCAGTGAG  Forward primer to amplify 
GRA3 to GRA3 3'UTR the 
genome of GRA3-mCherry 
strain; test location in genome 
oJR143 GCATGGTTGCAAAGTCCTGC  Reverse primer to amplify 
GRA3 to GRA3 3'UT the 
genome of GRA3-mCherry 
strain; also pair with oJR141 as 
the reverse primer to amplify 
HXGPRT to GRA3 3' UTR 
oJR144 TCGACGTCTTTGGAACGTGT Forward primer to amplify 
GRA7 to mCherry in the 
genome of GRA7-mCherry 
strain; test location in genome 
oJR145 CAAGTAGTCGGGGATGTCGG Reverse primer to amplify 
GRA7 to mCherry in the 
genome of GRA7-mCherry 
strain; test location in genome 
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oJR146 CAGAACGACAACAGCACAGG Forward primer to amplify 
HXGPRT to GRA7 3' UTR in 
the genome of GRA7-mCherry 
strain; test location in genome 
oJR150 TCCATTCGTCGCTACCGTTG Forward primer to amplify 
GRA7 to GRA7 3' UTR in the 
genome of GRA7-mCherry 
strain; test location in genome 
oJR151 CGGTAACGCGCATAAAACGA Reverse primer to amplify 
GRA7 to GRA7 3' UTR in the 








3.  RESULTS: 
A． Generation of GRA3-mCherry and GRA7-mCherry expressing strains using 
CRISPR/Cas9 
To label GRA3 and GRA7, we used a CRISPR-Cas9 system to insert mCherry 
into the genome. First, we created an RNA-guided Cas9 plasmid to target either GRA3 
or GRA7 in the genome. The guide RNA was designed using Eukaryotic Pathogen 
CRISPR guide RNA/DNA Design Tool (http://grna.ctegd.uga.edu/) and E-CRISPR 
(http://www.e-crisp.org/E-CRISP/) websites, and were chosen that were located at the 
3’ end of GRA3 or GRA7.  The Cas9 protein/ gRNA complex specifically targets GRA3 
or GRA7 in the genome of Toxoplasma and creates a double-stranded break (Figures 9 
and 10). Second, we created the targeting constructs containing GRA3 or GRA7, 
mCherry, HXGPRT, and GRA3 3’UTR or GRA7 3’UTR.  The mCherry was inserted on 
the C-terminus of GRA3 or GRA7 because these proteins contain an N-terminual 
secretory signal sequence.  GRA3 or GRA7 and its corresponding 3’UTR sequence on 
the targeting construct are used for homologous recombination to repair the DSB 
mediated by Cas9 nuclease (Figures 9 and 10). HXGPRT (hypoxanthine-xanthine-
guanine phosphoribosyl transferase) is involved in the Purine metabolism pathway 
(IMP) of T. gondii. Strains expressing HXGPRT activity can be selected in 
mycophenolic acid and xanthine (Pfefferkorn and Borotz, 1994). The parental 
Toxoplasma strain we used is Δku80Δhxgprt, in which the Ku80 mutation disrupts the 
parasite’s NHEJ pathway, resulting in a switch to homologous recombination (Huynh 
and Carruthers, 2009).  Transfected parasites expressing either GRA3-mCherry (Figure 
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11A) or GRA7-mCherry (Figure 11B) were detected under the microscope and selected 





Figure 9-Generation of the GRA3-mCherry expressing strain. The Cas9 protein and GRA3 gRNA are expressed from the same 
plasmid and bind together to form a complex. The Cas9 protein/GRA3 gRNA complex specifically targets GRA3 in the genome of 
Toxoplasma, and creates a double-stranded break (indicated with black triangle). The targeting construct was integrated into the parasite 









Figure 10-Generation of the GRA7-mCherry expressing strain. The Cas9 protein and GRA7 gRNA are expressed from the same 
plasmid and bind together to form a complex. The Cas9 protein/GRA7 gRNA complex specifically targets GRA7 in the genome of 
Toxoplasma and creates a double-stranded break (indicated with black triangle). The targeting construct was integrated into the parasite 









Figure 11-Transfected parasites expressing either GRA3-mCherry or GRA7-mCherry. The targeting constructs (GRA3-mCherry-
HXGPRT-GRA3 3’UTR or GRA7-mCherry-HXGPRT-GRA7 3’UTR) were digested and transfected, along with a plasmid expressing 
Cas9 and the appropriate gRNA, into the Δku80Δhxgprt parasite strain. After transfection, the presence of GRA3-mCherry (A) and 
GRA7-mCherry (B) was detected by infecting HFF cells with the transfected parasites for 24 hours. Nuclei were stained with DAPI 
(blue). Phase (left), fluorescent image (middle), merge (right). Images were deconvoluted and processed using Volocity Software.
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B． Confirmation of the genomic location of the mCherry targeting construct  
The insertion of mCherry into the GRA3 or GRA7 locus was verified by PCR. Primers 
were designed to amplify a 5’ region of the GRA3 or GRA7 gene (outside of the region 
used in the targeting construct) within the mCherry gene (Figures 12A and 13A). Likewise, 
primers were designed to amplify a region outside of the GRA3 or GRA7 3’ UTR to within 
the HXGPRT gene No bands were amplified from genomic preparations of Δku80Δhxgprt 
parasites, indicating the absence of the targeting constructs in the parental genome (Figures 
12B, 12C, 13B and 13C). PCR products of the expected size were amplified from the two 
clonal populations expressing GRA3-mCherry - 1334bp (GRA3 5’ UTR to mCherry) and 
2359bp (HXGPRT to the GRA3 3’UTR), indicating that the targeting construct is correctly 
integrated in the parasite genome (Figure 12B and 12C). Similar results were found for the 
GRA7-mCherry expressing strains (Figure 13B and 13C). Overall, our results show that 
the targeting construct is specifically inserted at the 3’ end of the GRA3 and GRA7 genes 





B                                                                   C 
                     
Figure 12-Confirmation of the insertion of mCherry at the 3’ end of GRA3 in the genome. A) Schematic representation of the 
targeting construct integrated into the GRA3 genomic locus. Primers used to confirm the insertion of the targeting construct by PCR are 
shown. B) and C) PCR of Δku80Δhxgprt and two GRA3-mCherry clonal populations. The P1/P2 primers were used to verify the presence 
of mCherry while the P3/P4 primers verified the presence of HXGPRT.  ΔΔ: Δku80Δhxgprt strain. A8E6 and C9F5: 2 clonal populations 






Figure 13-Confirmation of the insertion of mCherry at the 3’ end of the GRA7 
gene in the genome. A) Schematic representation of the targeting construct 
integrated into the GRA7 genomic locus. Primers used to confirm the insertion of 
the targeting construct by PCR are shown. B) and C) PCR of Δku80Δhxgprt and 
two clonal populations expressing GRA7-mCherry. The P1/P2 primers were used 
to verify the presence of mCherry while the P3/P4 primers verified the presence 
of HXGPRT.  ΔΔ: Δku80Δhxgprt strain. AD4 and BG2: 2 clonal populations 
expressing GRA7-mCherry. Primer 1: OJR144. Primer 2: OJR 145. Primer 3: 




C． Detection of GRA3-mCherry and GRA7-mCherry proteins by immunoblotting 
       Expression of GRA3-mCherry and GRA7-mCherry was detected by Western blot 
using anti-GRA3, anti-GRA7 and anti-mCherry antibodies. Based on the primary sequence, 
the predicted molecular weight of GRA3 is 24.25 kDa and of GRA7 is 25.86 kDa. The 
predicted molecular weight of mCherry is ~27 kDa. Expression of endogenous GRA3 (~24 
kDa) was detected in the Δku80Δhxgprt strain (Figure 14A). In the two clonal GRA3-
mCherry expressing strains, bands at ~51 kDa for GRA3-mCherry were detected either 
with anti-GRA3 antibody (Figure 14A) or by anti-mCherry antibody (Figure 14B), 
indicating the expression of GRA3-mCherry. Probing lysates from the Δku80Δhxgprt strain 
with antibodies against mCherry did not detect any bands, confirming the lack of mCherry 
in the parental strain. Additional bands with molecular weights between 25 kDa to 37 kDa 
were also detected in the GRA3-mCherry expressing strains. Those bands most likely 
represent degraded peptides.  
GRA7 was detected as a ~26 kDa band in Δku80Δhxgprt. GRA7-mCherry (~53 kDa) 
was detected in the two clonal GRA7-mCherry expressing strains either by anti-GRA7 
antibody (Figure 15A) or anti-mCherry antibody (Figure 15B). Several bands lower than 
GRA7-mCherry (~53 kDa) were also detected in the GRA7-mCherry strains (Figure 15A), 
indicating the cleavage of the GRA7-mCherry protein. In addition, a band lower than 
GRA7-mCherry (~53 kDa) was detected in GRA7-mCherry expressing strains by anti-




A                                                                  B 
        
Figure 14-Western blot analysis of GRA3-mCherry. Cell lysates from freshly egressed ΔKu80Δhxgprt and two clonal populations of 
GRA3-mCherry parasites were separated by SDS-PAGE. Blots were incubated with either anti-GRA3 antibody (A) or anti-mCherry 
antibody (B). Expression of GRA3 protein (24.25KDa) and GRA3-mCherry proteins (50.74KDa) were detected by chemiluminescence. 





A                                                            B 
      
Figure 15-Western blot analysis of GRA7-mCherry. Cell lysates from freshly egressed ΔKu80Δhxgprt and two clonal populations of 
GRA7-mCherry expressing strains were separated by SDS-PAGE. Blots were incubated with either anti-GRA7 antibody (A) or anti-
mCherry antibody (B). Expression of GRA3 protein (25.86 KDa) and GRA3-mCherry proteins (52.72KDa) were detected by 
chemiluminescence. ΔΔ: Δku80Δhxgprt strain. AD4 and BG2: 2 clonal populations of GRA7-mCherry strain. MW indicates the 
molecular weight markers in kilodaltons. 
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D． Localization assays for GRA3-mCherry and GRA7-mCherry 
To ascertain that the insertion of mCherry does not interfere with GRA7 or GRA3 
localization, immunofluorescence assays were used to compare the localization of GRA3 
or GRA7 in the Δku80Δhxgprt strain and GRA3-mCherry or GRA7-mCherry strains using 
anti-GRA3 or anti-GRA7 antibodies. Results show that the fluorescence signal of GRA3-
mCherry was in dense granules, on the PVM and on the IVN, similarly to the signal of 
anti-GRA3 antibody in the parental strain (Figure 16). This result indicates that the 
insertion of mCherry did not interfere with the localization of GRA3. Of note, we observed 
a stronger fluorescence signal for GRA3-mCherry in dense granules and IVN than on the 
PVM. As the size of the PV increased, the brightness of the GRA3-mCherry signal at the 
PVM decreased while it increased in dense granules and on the IVN. In contrast, the 
fluorescence signal of GRA7-mCherry remained mostly in dense granules; the distribution 
of GRA7-mCherry fluorescence was less at the PVM and IVN as compared to the parental 
strain, indicating that the insertion of mCherry slightly interfered with the localization of 
GRA7 (Figure 17).  
To confirm that the mCherry signal represents the intact fusion protein GRA3-
mCherry or GRA7-mCherry, we also compared the localization of the mCherry with GRA3 
or GRA7 immunofluorescence signals. GRA3 and GRA7 were detected with anti-GRA3 
and anti-GRA7 antibody, respectively. The level of colocalization of the two signals was 
measured using a positive product of the difference of the means (PDM). Colocalization 
results were represented using values of Pearson’s correlation coefficient (PCC). When 
comparing the localization of the mCherry and GRA3 signals in the GRA3-mCherry strain, 
PCC values were found above 0.70 (Figure 18), indicating the level of colocalization 
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between these two signals was very high. The highest PCC value (0.83) was found for PV 
containing 2 parasites in the 2-parasite PV (Figure 18).  As the size of the PV increased, 
the strongest colocalization signals were found on the IVN (shown in yellow on Figure 18). 
On the contrary, when comparing the localization of the mCherry and GRA7 signals in the 
GRA7-mCherry strain, the PCC values were below 0.50 (Figure 19), indicating a low level 
of colocalization. The overall colocalization signals of mCherry and GRA7 shown in 







Figure 16- Comparison of GRA3 and GRA3-mCherry localization. HFF were infected 
with either Δku80Δhxgprt or GRA3-mCherry expressing parasites for 24 hours and stained 
for DAPI (blue) and anti-GRA3 (green). Images were deconvoluted and processed using 
Volocity Software. Scale bar for each: 5μm. Merged: merged channels of anti-GRA3 















Figure 17- Comparison of GRA7 and GRA7-mCherry localization. HFF were infected 
with either Δku80Δhxgprt or GRA7-mCherry expressing parasites for 24 hours and stained 
for DAPI (blue) and anti-GRA7 (green). Images were deconvoluted and processed using 
Volocity Software. Scale bar for each: 5μm. Merged: merged channels of anti-GRA7 
staining and GRA7-mCherry.  
 










Figure 18-Localization of mCherry and 
GRA3 in GRA3-mCherry strain. HFFs were 
infected with GRA3-mCherry parasites for 24 
hours and immunostained for DAPI (blue) and 
anti-GRA3 (green) antibody. To measure the 
regions of colocalization, a positive product of 
the difference of the means (PDM; yellow in 
panels) for mCherry-tagged GRA3 and 
antibody-tagged GRA3 was analyzed in 
Volocity Software. The levels of 
colocalization were determined using 
Pearson’s correlation coefficient (PCC). Scale 





Figure 19-Localization of mCherry and 
GRA7 in GRA7-mCherry strain. HFFs 
were infected with GRA7-mCherry parasites 
for 24 hours and immunostained for DAPI 
(blue) and anti-GRA7 (green) antibody. To 
measure the regions of colocalization, a 
positive product of the difference of the 
means (PDM; yellow in panels) for 
mCherry-tagged GRA7 and antibody-tagged 
GRA7 was analyzed in Volocity Software. 
The level of colocalization was determined 
using Pearson’s correlation coefficient 
(PCC). Scale bar for each: 11μm. 
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E． Growth Assays for GRA3-mCherry and GRA7-mCherry 
To investigate if the insertion of mCherry at the C-terminus of GRA3 or GRA7 may 
have disrupted the parasite’s development, the growth of the GRA3-mCherry and GRA7-
mCherry strains were compared to that of the parental Δku80Δhxgprt strain. Two types of 
growth assays were performed: the intracellular replication assay and the plaque assay.  
Toxoplasma replicates approximately every 8 hours. For the intracellular replication 
assay, HFF cells were infected with parasites for 30 min, extracellular parasites were 
eliminated by washing with PBS and then replication was allowed to continue for 20 hours, 
thus for 2 to 3 cycles of division. The number of parasites per PV were counted, using a 
microscope, with 100 PVs counted per sample. No difference was noticed in the number 
of parasites per PV between the parental and GRA3-mCherry strains (Figure 20A), or 
between the parental and GRA7-mCherry strains (Figure 20B).  
Plaque assays were performed by infecting HFF monolayers grown in 6-well culture 
plates with 100 parasites for 6 days, allowed several cycles of parasite invasion, replication 
and egress. After fixation, cells were stained with crystal violet (Figure 21A and 21B). The 
number of plaques was assessed, and the area of plaques was measured through Volocity 
software. There was no significant difference in the number of plaques between HFF cells 
infected with the Δku80Δhxgprt strain and either the GRA3-mCherry or GRA7-mCherry 
strains (Figure 21C and 21D). Comparing the plaque areas of the Δku80Δhxgprt strain with 
either the GRA3-mCherry or GRA7-mCherry strains showed no significant differences as 
well (Figure 21 E and 21F).  
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In summary, results from our growth assays indicate that tagging GRA3 or GRA7 at the 





Figure 20-Intraceullar replication of Δku80Δhxgprt, GRA3-mCherry and GRA7-
mCherry strains. Coverslips of HFF were infected with Δku80Δhxgprt, GRA3-mCherry 
or GRA7-mCherry expressing strains. The number of parasites per PV was counted after 
20 hours of infection. The data shown are mean values + SD from three independent 
experiments. No statistically significant differences between Δku80Δhxgprt and GRA3-
mCherry or GRA7-mCherry strains were measured using a paired-T test. Figures were 
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Figure 21-Plaque Assays of Δku80Δhxgprt, GRA3-mCherry and GRA7-mCherry 
strains. HFF were infected with 100 parasites of each strain and incubated at 37°C for 6 
days. Two clonal populations of GRA3-mCherry or GRA7-mCherry were used. After 
incubation, cells were fixed with 100% ethanol and stained with crystal violet. The number 
of plaques was counted, and the area of each plaque was measured using Volocity software. 
The data shown are mean values + SD from three independent experiments. No statistically 
significant difference was measured using a one-way ANOVA test. Figures were generated 
using Graph Pad Prism software. WT: Δku80Δhxgprt strain. AD4 and BG2: 2 clonal 













F． Live cell imaging 
We chose the GRA3-mCherry expressing strains for live cell imaging because these 
strains have a better GRA3-mCherry signals and the mCherry is not cleaved in the parasite. 
We infected HFF cells with GRA3-mCherry expressing parasites and monitored events at 
the PV dynamically through time-lapse analysis. The PVM, dense granules and IVN were 
labeled by GRA3-mCherry, which is shown in white (Figure 22). Dense granule organelles 
were observed moving around inside the parasites (yellow box in Figure 22A). Two PV 
with close contact through their PVM were observed (Figure 22B). We observed that the 
IVN changed its shape during the movie (Figure 22B). For example, in the top PV, the IVN 
in the boxed region appeared to elongate; the IVN appeared to contact in the lower PV in 
the boxed region.  PVM projections (PVMP) were observed connecting two PV (Figure 
22C) and were observed extending into the host cytoplasm (Figure 22D, 22E, and 22F). 
PVMP was found to connect two PVs (Figure 22D) though little to no movement was 
detected in the time frame observed. Multiple PVMP of different lengths were detected 
extending from one PV. Potential movements of the longer PVMP, which is greater than 
10 μm, was indicated with red arrows in Figure 22 D. The shorter PVMP, which was 
shorter than 5 μm, (yellow box in Figure 22E and 22F) retracted and elongated during the 
different time points, showing that the PVMP can be dynamic.  
To study interactions between host vesicles and the PVM, we infected VERO cells 
stably expressing GFP-tagged Rab11A with GRA3-mCherry expressing parasites. In time-
lapse microscopy, host GFP-Rab11A vesicles were observed inside the PV or close to the 
PVM (Figure 23). GFP-Rab11A vesicles found inside the PV localized primarily to the 
IVN region and most remained in the same area with little movement during the time frame 
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of the movie (Figure 23 B and 23C; white box). Some vesicles, however, were detected to 
move along the IVN (Figure 23 A and D; white box). These findings may indicate possible 
interactions between the IVN and host GFP-Rab11A vesicles inside PV. Some GFP-
Rab11A vesicles moved to the PV and closely contacted the PVM. In some cases, the host 
vesicle remained in contact with the PVM throughout the duration of the movie (Figure 
23D; blue arrows) or transiently contacted the PVM (Figure 23B, and 23D; white arrows). 
In Figure 24E, a GFP-Rab11A vesicle was first found to contact the PVM and then was 
found inside the PV 20 sec later, indicating the possible entry of host GFP-Rab11A vesicles 





















Figure 22-Snapshots of the PV of GRA3-mCherry expressing parasites at different time points. HFF cells were infected with 
GRA3-mCherry expressing parasites for 20 hours. Live cell imaging was done using the Delta Vision Elite Deconvolution Microscope. 
Images were processed and adjusted using ImageJ. Time (left top) and scale bars (right bottom) are shown. GRA3-mCherry is detected 
on the PVM, dense granules and IVN. Movement of dense granules and IVN can be observed at different time points. A) a single 4-
parasite PV with movements of dense granules in the yellow square; Duration=2 min, Time lapse=5 sec.  B) close contact between 2 
PVs through PVM highlighted in the yellow square; Duration=2 min, Time lapse=5 sec. C) 2 PVs connected with each other through a 
PVMP in a yellow square; Duration=30 sec, Time lapse=5 sec. D, E & F) a single 4-parasite PV with extensions and retraction of a 
PVMP; Duration=5 min, Time lapse=20 sec. Potential movements of the PVMP in D was indicated with red arrows in yellow box. 
Movements of PVMP in E & F was highlighted in yellow box Brightness and contrast settings were increased to show PVMP in C, D, 

























Figure 23-Interactions between host Rab11A vesicles and the PVM. VERO cells stably expressing GFP-Rab11 (green) were infected 
with GRA3-mCherry expressing parasites for 20 hours. Live cell imaging was done using a Delta Vision Elite Deconvolution 
Microscope. Images were processed and adjusted using ImageJ. PVM, dense granules and IVN are labeled by GRA3-mCherry, shown 
in red. Time (left top) and scale bars (right bottom) are shown. Host GFP-Rab11A vesicles found in the PV are highlighted with white 
squares. Host GFP-Rab11 vesicles found to stay close to the PVM for the entire video are indicated with blue arrows. Host GFP-Rab11 
vesicles found to close contact to the PVM and then left are indicated with white arrows. Images from D & E are the same PV but 
different z-slices. The fourth image in panel C, and images in panel E were adjusted due to photobleaching. IVN=tubulovesicular 
network of membranous tubules; PVM=parasitophorous vacuole membrane; DG=dense granule. A) Duration=5 min, Time lapse=15 






Toxoplasma is an obligate intracellular parasite that scavenges host nutrients for 
survival. Previous data from our lab has shown that T. gondii intercepts host Rab trafficking 
pathways and internalizes host Rab vesicles into the PV (Romano et al., 2017a; Romano et 
al., 2013), possibly for nutrient acquisition. As the PVM does not fuse with these host 
vesicles, the mechanisms of Rab vesicles internalization into the PV is not clear. To further 
explore the mechanism, requires a dynamic view of the interactions between host vesicles 
and the PVM. Therefore, the major goal of my master’s thesis is to generate parasite strains 
expressing fluorescent markers on the PVM and analyze the movement of the PVM over 
time relative to host Rab vesicles through live cell imaging.        
To study the dynamic interactions between the PVM and host organelles, we 
successfully engineered Toxoplasma strains that stably express a fluorescently-labeled 
PVM protein, either GRA3 or GRA7, using the CRISPR/Cas9 system. This gene editing 
system was able to specifically target GRA3 or GRA7 for the insertion of mCherry at the 
3’ end of the gene with high efficiency. We confirm that the insertion of mCherry does not 
affect parasite replication based on microscopy growth assays nor does it affect invasion, 
replication or egress based on plaque assays. The mCherry-labeled GRA3 protein localized 
to the dense granules, IVN and PVM, which has a similar localization pattern compared to 
antibody localized GRA3 in the parental strain. However, most GRA7-mCherry protein 
localizes to the dense granules rather than the PVM or IVN. In addition, a higher 
colocalization level was measured for GRA3-mCherry strain than for GRA7-mCherry strain 
when comparing the signals of mCherry and antibody localized GRA3 or GRA7. It is 
possible that the difference in colocalization between mCherry and anti-GRA7 antibody 
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fluorescence is due to cleavage of mCherry from the GRA7 protein in the dense granules, 
which correlates with the results of the western blot analysis. Another possibility would be 
that mCherry masks some GRA7 antigens. As a result, the GRA3-mCherry expressing 
strains were selected for live cell imaging. 
GRA3-mCherry expressing parasites show us a clearly dynamic view of the PVM, 
IVN and dense granules. Through live cell imaging, we observed rapid movement of dense 
granules inside parasites and the IVN in the PV. We also observed contacts between two 
PVs either through a direct PVM-PVM or PVMP connection, indicating that the PVM 
might play a role in the interaction between two PVs. PVMP, which is decorated with GRA 
proteins (Dubremetz et al., 1993; Jacobs et al., 1998; Rome et al., 2008; Romano et al., 
2013), is a unique feature of the PVM. Several previous studies have shown that PVMP 
extend throughout the host cytosol and can interact with host organelles. For example, 
PVMP are found to contact the microtubule-organizing center (MTOC), Golgi, or other 
PVs in the same host cell or adjacent cells (Coppens et al., 2006; Rome et al., 2008), 
indicating its dynamic nature. In this study, we were the first to observe the dynamics of 
PVMPs in live cells. We observed one PV with three PVMPs extending into host cytosol– 
two short PVMPs (less than 5μm) and one more than 10μm. One of the short PVMPs 
retracted and elongated into the host cytosol during a 140-sec time frame, while no 
movement was observed for the other short one. Partial movements were observed for the 
long PVMP. No movement was observed for the PVMP connecting between two PV as 
well. Our observations indicate that PVMP can be very diverse, either being dynamic or 
motionless.  To gain the number of PVMP forms per PV, and how stable they are, it would 
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be interesting to investigate PVMP dynamics during a longer time period by live cell 
imaging.  
Previous studies have shown that host Rab vesicles involved in anterograde, recycling, 
and endocytic pathways, are found inside the PV (Nolan et al., 2017; Romano et al., 2017; 
Romano et al., 2013). To investigate the interactions between host vesicles and the PVM, 
we infected VERO cells stably expressing GFP-Rab11a with GRA3-mCherry expressing 
parasites. Previous studies in our lab have shown that the IVN contributes to host vesicle 
sequestration (Romano et al. 2017), and we were able to confirm this role for IVN in our 
study. Host GFP-Rab11A vesicles were localized in the IVN region and some of them 
appeared to be transported along the IVN at different time points. This observation might 
indicate that the IVN not only plays a role in sequestering host vesicles, but may also play 
a role in transporting host vesicles inside the PV.  
Interactions between the PVM and host Rab11A vesicles are diverse. We observed 
that some host Rab11A vesicles remain closely associated with the PVM while others only 
briefly contact the PVM. In one PV, a host Rab11A vesicle was first observed to closely 
contact the PVM, and then was found inside the PV, in the IVN region. This finding, along 
with evidence from previous studies (Romano et al., 2017a; Romano et al., 2013), suggests 
that host Rab vesicles can cross the PVM to be fully internalized into the PV. However, we 
were not able to capture the moment of host vesicle entry into the PV, because the exposure 
time for GFP-Rab11A was too long to allow for a short enough time-lapse setting. To 
overcome this problem, we are now creating a cell line that stably expresses mEmerald-
Rab11A, which should be brighter and more photostable, thus allowing for a shorter 
exposure settings and consequently smaller intervals between time-lapse timepoints.  
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Two different mechanisms have been described for the entry of host vesicles into the 
PV. In one, the entry of host vesicles may be facilitated by host microtubules pushing into 
the PVM, forming invaginations that function as conduits, which are termed “host 
organelle-sequestering tubule structures” or H.O.S.T. (Coppens et al. 2006; Romano et al., 
2013). In the other, host Rab vesicles may be internalized into regions where the tubules 
of the IVN connect to and fuse with the PVM, forming conduits or gate of entry for host 
vesicles (Romano et al., 2017). It would be interesting to use live cell imaging to inspect 
the dynamic of host microtubules pocking onto the PVM at location where host vesicles 
penetrate the PV. 
FUTURE DIRECTIONS: 
         In summary, we successfully created a Toxoplasma strain that stably expresses a 
fluorescently labeled PVM protein. Using this strain, we were able to study the dynamic 
movements of PVMP, and interactions between the PVM and host Rab vesicles through 
live cell imaging. For future studies, we are interested in investigating how host Rab11A 
vesicles pass through the PVM into the PV. We are also interested in studying the function 
of PVMPs, as well as their interactions with host organelles.  
Toxoplasma PVM not only interacts with host Rab vesicles, but also with other host 
organelles. After invasion, multiple host organelles are recruited to and associate with the 
PV, a process that is hypothesized to function in nutrient acquisition by the parasite. 
(Coppens, 2014). For example, parasite growth is dependent on lipoate from host 
mitochondria, thus, making PV-associated mitochondria a possible source for this 
metabolite (Crawford et al. 2006). Other studies provide evidence that T. gondii may 
scavenge phospholipids from the ER (Pratt et al., 2013), indicating a role for PVM-
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associated ER in lipid acquisition. The host Golgi, which associates with the PV, is also a 
source of sphingolipids for the parasite (Romano et al., 2013). In addition, association 
between the PV and MTOC results in the reorganization of the microtubular network 
around the PV and recruitment of host vesicles to the PV (de Melo and De Souza, 1996; 
Coppens et al., 2006; Romano et al., 2013). However, the molecular mechanisms of these 
interactions between the PVM and host organelles, for nutrition acquisition, remain to be 
determined. Besides, these previous findings are all based on fixed cells analyzed by 
fluorescence and electron microscopy.  Therefore, we are interested in studying the 
dynamic interactions between PVM and other host organelles in more details over time. 
By infecting cells expressing different organelle markers with the GRA3-mCherry 
expressing parasites, we will be able to investigate PVM-host organelle interactions 
through live cell imaging at different points during infection. Also, adding fluorescently 
labeled lipids to the medium of cells infected with GRA3-mCherry expressing parasites, 
we will be able to analyze the role of the PVM and IVN in the internalization of host lipids 
into the PV.  
A better understanding of how the PVM interacts with host organelles, the parasite 
internalizes host vesicles into its PV and scavenges host lipids from intra-PV vesicles will 
provide insight important for our long-term goal of identifying possible drug targets to treat 
Toxoplasma infections in the nutrient salvage pathways These potential drug targets can 
be parasite effectors that attach to host organelles or vesicles, internalize host vesicles or 
release host nutrients from host organelles or vesicles. Molecular interference with these 






1. Zhao, T., et al., Immunogenicity of induced pluripotent stem cells Immunogenicity 
of induced pluripotent stem cells. Nature, 2011. 474 (7350): p. 212-215.  
2. Zhang, F., X. Guo, and Y. Wen, CRISPR/Cas9 for genome editing: progress, 
implications and challenges. Human Molecular Genetics, 2014. 23(R1): p. R40-R46. 
3. Wang, Z.-D., et al., Prevalence and burden of Toxoplasma gondii infection in HIV-
infected people: a systematic review and meta-analysis. The Lancet HIV, 2017. 4(4): p. 
177-188. 
4. Wang, J.L., et al., Evaluation of the basic functions of six calcium-dependent 
protein kinases in Toxoplasma gondii using CRISPR-Cas9 system. Parasitology Research, 
2016. 115(2): p. 697-702. 
5. Walker, M.E., et al., Toxoplasma gondii actively remodels the microtubule network 
in host cells. Microbes and Infection, 2008. 10 (14-15): p. 1440-1449. 
6. Vinayak, S., et al., Genetic Manipulation of the Toxoplasma gondii genome by 
fosmid recombineering. mBio, 2014. 5(6): p. e02021-14. 
7. Torgerson, P.R. and P. Mastroiacovo, The global burden of congenital 
toxoplasmosis: a systematic review. Bull World Health Organ, 2013. 91(7): p. 501-508. 
8. Tonkin, M.L., et al., Host Cell Invasion by Apicomplexan Parasites: Insights from 
the Co-Structure of AMA1 with a RON2 Peptide. Science, 2011. 333(6041): p. 463-467. 
9. Sinai, A.P., P. Webster, and K.A. Joiner, Association of host cell endoplasmic 
reticulum and mitochondria with the Toxoplasma gondii parasitophorous vacuole 
membrane: a high affinity interaction. The Journal of Cell Science, 1997. 110 (Pt 17): p. 
2117-2128. 
10. Sibley, L.D., et al., Regulated secretion of multi-lamellar vesicles leads to 
formation of a tubulo-vesicular network in host-cell vacuoles occupied by Toxoplasma 
gondii. The Journal of Cell Science, 1995. 108 (Pt 4): p. 1669-1677. 
11. Shen, B., et al., Efficient Gene Disruption in Diverse Strains of Toxoplasma gondii 
using CRISPR/CAS9. mBio, 2014. 5(3): p. e01114-14. 
12. Shen, B., et al., Development of CRISPR/Cas9 for efficient genome editing in 
Toxoplasma gondii. Methods in Molecular Biology, 2017. 1498: p. 79-103. 
13. Seabra, S.H., et al., Endogenous polyamine levels in macrophages is sufficient to 
support growth of Toxoplasma gondii. The Journal of Parasitology, 2004. 90(3): p. 455-
460. 
14. Schwartzman, J.D. and E.R. Pfefferkorn, Toxoplasma gondii: Purine synthesis and 
salvage in mutant host cells and parasites. Experimental Parasitology, 1982. 53(1): p. 77-
86. 
15. Schwab, J.C., C.J. Beckers, and K.A. Joiner, The parasitophorous vacuole 
membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. 
Proceedings of the National Academy of Sciences of the United States of America, 1994. 
91(2): p. 509-513. 
16. Schindelin, J., et al., Fiji: an open-source platform for biological-image analysis. 
Nature Methods, 2012. 9(7): p. 676-682. 
67 
 
17. Rosowski, E.E., et al., Strain-specific activation of the NF-κB pathway by GRA15, 
a novel Toxoplasma gondi dense granule protein. The Journal of Experimental Medicine, 
2011. 208(1): p. 195-212. 
18. Rome, M.E., et al., Intervacuolar Transport and Unique Topology of GRA14, a 
Novel Dense Granule Protein in Toxoplasma gondii. Infection and Immunity, 2008. 76(11): 
p. 4865-4875. 
19. Romano, J.D., et al., Toxoplasma gondii salvages sphingolipids from the host Golgi 
through the rerouting of selected Rab vesicles to the parasitophorous vacuole. Molecular 
Biology of the Cell, 2013. 24(12): p. 1974-1995. 
20. Romano, J.D., et al., The parasite Toxoplasma sequesters diverse Rab host vesicles 
within an intravacuolar network. The Journal of Cell Biology, 2017. 216(12): p. 4235-4254. 
21. Robert-Gangneux, F. and M.-L. Dardé, Epidemiology of and diagnostic strategies 
for Toxoplasmosis. Clinical Microbiology Reviews, 2012. 25(2): p. 264-296. 
22. Rajapakse, S., et al., Antibiotics for human Toxoplasmosis: a systematic review of 
randomized trials. Pathogens and Global Health, 2013. 107(4): p. 162-169. 
23. Pratt, S., et al., Sphingolipid synthesis and scavenging in the intracellular 
apicomplexan parasite, Toxoplasma gondii. Molecular and Biochemical Parasitology, 
2013. 187(1): p. 43-51. 
24. Pfefferkorn, E.R., Interferon gamma blocks the growth of Toxoplasma gondii in 
human fibroblasts by inducing the host cells to degrade tryptophan. Proceedings of the 
National Academy of Sciences of the United States of America, 1984. 81(3): p. 908-912. 
25. Nolan, S.J., J.D. Romano, and I. Coppens, Host lipid droplets: An important source 
of lipids salvaged by the intracellular parasite Toxoplasma gondii. Public Library of 
Science Pathogens, 2017. 13(6): p. e1006362. 
26. Neville, A.J., et al., Clinically available medicines demonstrating anti-Toxoplasma 
activity. Antimicrobial Agents and Chemotherapy, 2015. 59(12): p. 7161-7169. 
27. Nam, H.W., GRA proteins of Toxoplasma gondii: maintenance of host-parasite 
interactions across the parasitophorous vacuolar membrane. The Korean Journal of 
Parasitology, 2009. 47 Suppl: p. S29-37. 
28. Moudy, R., T.J. Manning, and C.J. Beckers, The loss of cytoplasmic potassium 
upon host cell breakdown triggers egress of Toxoplasma gondii. The Journal of Biological 
Chemistry, 2001. 276(44): p. 41492-41501. 
29. Mordue, D.G., et al., Invasion by Toxoplasma gondii establishes a moving junction 
that selectively excludes host cell plasma membrane proteins on the basis of their 
membrane anchoring. The Journal of Experimental Medicine, 1999. 190(12): p. 1783-1792. 
30. Montazeri, M., et al., A systematic review of in vitro and in vivo activities of anti-
Toxoplasma drugs and compounds (2006-2016). Frontiers in Microbiology, 2017. 8: p. 25-
25. 
31. Molestina, R.E., et al., Activation of NF-κB by Toxoplasma gondii correlates with 
increased expression of antiapoptotic genes and localization of phosphorylated IκB to the 




32. Miller, C.M., et al., The immunobiology of the innate response to Toxoplasma 
gondii. The International Journal for Parasitology, 2009. 39(1): p. 23-39. 
33. Mercier, C., et al., Biogenesis of nanotubular network in Toxoplasma 
parasitophorous vacuole induced by parasite proteins. Molecular Biology of the Cell, 2002. 
13(7): p. 2397-2409. 
34. Mercier, C. and M.-F. Cesbron-Delauw, Toxoplasma secretory granules: one 
population or more? Trends in Parasitology, 2015. 31(2): p. 60-71. 
35. McCoy, J.M., et al., TgCDPK3 regulates calcium-dependent egress of Toxoplasma 
gondii from host cells. Public Library of Science Pathogens, 2012. 8(12): p. e1003066. 
36. Martin, A.M., et al., The Toxoplasma gondii parasitophorous vacuole membrane: 
transactions across the border. The Journal of Eukaryotic Microbiology, 2007. 54(1): p. 
25-28. 
37. Ma, J.S., et al., Selective and strain-specific NFAT4 activation by the Toxoplasma 
gondii polymorphic dense granule protein GRA6. The Journal of Experimental Medicine, 
2014. 211(10): p. 2013-2032. 
38. Laliberté, J. and V.B. Carruthers, Host cell manipulation by the human pathogen 
Toxoplasma gondii. Cellular and Molecular Life Sciences, 2008. 65(12): p. 1900-1915. 
39. Khan, A. and M.E. Grigg, Toxoplasma gondii: Laboratory maintenance and growth. 
Current Protocols in Microbiology, 2017. 44: p. 20c.1.1-20c.1.17. 
40. Kafsack, B.F.C., et al., Rapid membrane disruption by a perforin-like protein 
facilitates parasite exit from host cells. Science, 2009. 323(5913): p. 530-533. 
41. Jacobs, D., et al., Identification and heterologous expression of a new dense granule 
protein (GRA7) from Toxoplasma gondii. Molecular and Biochemical Parasitology, 1998. 
91(2): p. 237-249. 
42. Huynh, M.-H. and V.B. Carruthers, Tagging of endogenous genes in a Toxoplasma 
gondii strain lacking Ku80. Eukaryotic Cell, 2009. 8(4): p. 530-539. 
43. Hussain, M.A., et al., Toxoplasma gondii in the food supply. Pathogens, 2017. 6(2): 
p. 21. 
44. Goldszmid, R.S., et al., Host ER-parasitophorous vacuole interaction provides a 
route of entry for antigen cross-presentation in Toxoplasma gondii-infected dendritic cells. 
The Journal of Experimental Medicine, 2009. 206(2): p. 399-410. 
45. Gold, D.A., et al., The Toxoplasma dense granule proteins GRA17 and GRA23 
mediate the movement of small molecules between the host and the parasitophorous 
vacuole. Cell Host Microbe, 2015. 17(5): p. 642-652. 
46. Gaji, R.Y., et al., Phosphorylation of a myosin motor by TgCDPK3 facilitates rapid 
initiation of motility during Toxoplasma gondii egress. Public Library of Science 
Pathogens, 2015. 11(11): p. e1005268. 
47. Fox, B.A., J.P. Gigley, and D.J. Bzik, Toxoplasma gondii lacks the enzymes 
required for de novo arginine biosynthesis and arginine starvation triggers cyst formation. 
The International Journal of Parasitology, 2004. 34(3): p. 323-331. 
48. Ferguson, D.J.P., Use of molecular and ultrastructural markers to evaluate stage 
conversion of Toxoplasma gondii in both the intermediate and definitive host. International 
The Journal for Parasitology, 2004. 34(3): p. 347-360. 
69 
 
49. Dubremetz, J.F., et al., Kinetics and pattern of organelle exocytosis during 
Toxoplasma gondii/host-cell interaction. Parasitology Research, 1993. 79(5): p. 402-408. 
50. Dubey, J.P., et al., Sporulation and survival of Toxoplasma gondii oocysts in 
different types of commercial cat litter, 2011. Journal of Parasitology, 97(5): p.751-754 
51. Dimier, I.H. and D.T. Bout, Interferon-gamma-activated primary enterocytes 
inhibit Toxoplasma gondii replication: a role for intracellular iron. Immunology, 1998. 
94(4): p. 488-495. 
52. de Melo, E.J. and W. de Souza, A cytochemistry study of the inner membrane 
complex of the pellicle of tachyzoites of Toxoplasma gondii. Parasitology Research, 1997. 
83(3): p. 252-256. 
53. de Melo, E.J., T.U. de Carvalho, and W. de Souza, Penetration of Toxoplasma 
gondii into host cells induces changes in the distribution of the mitochondria and the 
endoplasmic reticulum. Cell Structure and Function, 1992. 17(5): p. 311-317. 
54. Cribbs, A. P., & Perera, S. (2017). Science and bioethics of CRISPR-Cas9 gene 
editing: an analysis towards separating facts and fiction. The Yale Journal of Biology and 
Medicine, 90(4), 625–634.  
55. Crawford, M.J., et al., Toxoplasma gondii scavenges host-derived lipoic acid 
despite its de novo synthesis in the apicoplast. The European Molecular Biology 
Organization Journal, 2006. 25(13): p. 3214-3222. 
56. Coster, L.O.B., Parasitic Infections in solid organ transplant recipients. Infectious 
Disease Clinics of North America, 2013. 27(2): p. 395-427. 
57. Coppens, I., A.P. Sinai, and K.A. Joiner, Toxoplasma gondii exploits host low-
density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. The Journal 
of Cell Biololy, 2000. 149(1): p. 167-180. 
58. Coppens, I. and K.A. Joiner, Host but not parasite cholesterol controls Toxoplasma 
cell entry by modulating organelle discharge. Molecular biology of the Cell, 2003. 14(9): 
p. 3804-3820. 
59. Coppens, I., et al., Toxoplasma gondii Sequesters lysosomes from mammalian 
hosts in the vacuolar space. Cell, 2006. 125(2): p. 261-274. 
60. Coppens, I., Exploitation of auxotrophies and metabolic defects in Toxoplasma as 
therapeutic approaches. The International Journal of Parasitology, 2014. 44(2): p. 109-120. 
61. Charron, A.J. and L.D. Sibley, Host cells: mobilizable lipid resources for the 
intracellular parasite Toxoplasma gondii. The Journal of Cell Science, 2002. 115(15): p. 
3049-3059. 
62. Carruthers, V.B. and L.D. Sibley, Sequential protein secretion from three distinct 
organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. The 
European Journal of Cell Biololy, 1997. 73(2): p. 114-123. 
63. Boyer, K., et al., Unrecognized ingestion of Toxoplasma gondii oocysts leads to 
congenital Toxoplasmosis and causes epidemics in North America. Clinical Infectious 
Disease, 2011. 53(11): p. 1081-1089. 
64. Blader, I.J., et al., Lytic cycle of Toxoplasma gondii: 15 years later. Annual Review 
of Microbiology, 2015. 69: p. 463-485. 
70 
 
65. Beghetto, E., et al., Identification of a human immunodominant B-cell epitope 
within the GRA1 antigen of Toxoplasma gondii by phage display of cDNA libraries. The 
International Journal of Parasitology, 2001. 31(14): p. 1659-1668. 
66. Barrangou, R., et al., CRISPR provides acquired resistance against viruses in 
prokaryotes. Science, 2007. 315(5819): p. 1709-1712. 
67. Bai, M. J., et al., Functional characterization of dense granule proteins in 
Toxoplasma gondii RH strain using CRISPR-Cas9 system. Frontiers in Cellular and 







108W.39th Street, Baltimore, MD, 21210 
Mobile phone:920-931-5682; luqiong.wang113@gmail.com  
EDUCATION:  
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD                 May 2019 
• Master of Science in Molecular Microbiology and Immunology                                
 
Lawrence University, Appleton, WI                                                      Aug 2013-Jun 2017 
• Bachelor of Arts in Biology & minor in Anthropology 
 
RESEARCH EXPERIENCES:  
• Master Thesis & Research Assistant, Coppens Lab 
Johns Hopkins School of Public Health, Baltimore, MD                          Nov 2017-Present 
Title: Investigating the Dynamics of the Interaction between Mammalian Host Organelles 
and Toxoplasma 
The goal of my thesis research is to investigate the dynamic interaction between 
mammalian host organelles, such as GFP-Rab-11 vesicles, and the parasitophorous vacuole 
membrane (PVM) of Toxoplasma through live cell imaging. To achieve this goal, I 
engineered Toxoplasma strains that stably express a fluorescently-labeled (mCherry) PVM 
protein (GRA3 or GRA7) using CRISPR/Cas9. I designed primers and performed PCR to 
confirm the insertion of mCherry in the correct location in the parasite genome. I also 
performed growth and localization assays to confirm that tagging GRA3 and GRA7 does 
not alter the localization of the proteins or the ability of the parasites to grow normally. 
Following confirmation, I used these strains for live cell imaging to observe the interaction 
between host GFP-Rab-11 vesicles and the PVM. Those parasite strains will also be 
valuable as a tool to study various interactions between PVM and other host organelles in 
future research.  
 
• Senior Capstone Project, Humphries Lab 
Lawrence University, Appleton, WI                                                      Sept 2016-Jun 2017 
Title: Molecular characterization and immune responses of macrophage expressed gene 
from freshwater snail, Biomphalaria glabrata 
Macrophage expressed genes (Mpegs) encode members of the membrane-attack 
complex/perforin protein superfamily that have been shown to play essential roles in 
antibacterial activities in some mollusks. The role of Mpegs is unknown in the freshwater 
snail, Biomphalaria glabrata, which is the vector of Schistosoma mansoni. To understand 
its role in B.glabrata, I first used different genetic analysis tools to characterize Mpeg in 
the snail genome, determined their distribution in various snail tissues, and compared its 
homologs to those of other species. I then designed and optimized protocols for cloning, 
expressing and purifying one of the B.glabrata Mpeg proteins I identified in bacteria for 
future immunological assays. By the end of my project, I was able to detect purified Mpeg 
protein with an anti-human Mpeg antibody, which proves its conservation across species.  







• Summer Research Assistant, LaBelle Lab 
University of Chicago, Chicago, IL         Jun 2016-Aug 2016 
Title: Cloning of CD19 single chain variable fragment (scFv) for a new peptide-based 
therapeutic delivery system 
The overall goal of this project was to design a novel drug delivery system to increase the 
stability in circulation, cellular permeability and cell-specific targeting of peptide drugs. 
This delivery system has therapeutic peptides containing hydrophobic tails which will self-
assemble to form a micellular nanoparticle, and antibody fragments binding to the 
nanoparticle. My project focused on the antibody fragments of the delivery system, in 
which I used various molecular techniques to clone, express and isolate a scFv against 
CD19 expressed on normal and malignant B cells. I was also able to use flow cytometry to 
test the binding ability of purified scFv protein to CD19 on human lymphoma B cells and 
other controls. The flow cytometry indicated that the purified scFv fragment bound 
specifically to CD19 expressed on B cells. 
  
• Research Assistant & Independent Study, Humphries Lab 
Lawrence University, Appleton, WI                                                      Sept 2015-Jun.2016 
During the academic year, I worked on two research projects. The first one was to 
investigate whether the TLR signaling pathway is involved in the regulation of immune-
related genes in B. glabrata, which was not widely-studied yet. In this project, I used PCR 
and gel electrophoresis to examine transcriptional levels of different genes involved in the 
TLR pathway in the B. glabrata embryonic cell line (Bge cells). Results showed that genes 
involved in the TLR pathway are present in Bge cells, indicating the possible role of the 
TLR pathway in B. glabrata immunity. The second project was to use PCR and gel 
electrophoresis to determine whether Bge cells express Mpeg. During the project, I also 
helped to optimize the PCR protocol. Results showed that the Mpeg is transcribed in Bge 
cells, indicating its possible immunological role in B. glabrata. This project was also the 
starting point for my senior capstone project. 
 
AWARDS & HONORS 
Johns Hopkins Bloomberg School of Public Health            Aug 2018 
• MMI Departmental Tuition Fellowship                                  
 
Lawrence University                                                                              Aug 2013-Jun 2017 
• 2016-2017 Dean’s list 
• Four-year International Student Scholarship  
• 2017 Chandler Senior Experience Funds 
• 2016 Summer Research Fellowship 
 
MEMBERSHIP: 











• L. Wang, J. Romano, I. Coppens. Investigating the Dynamics of the Interaction 
between Mammalian Host Organelles and Toxoplasma. Presented to The Delta Omega 
Scientific Poster Competition at Johns Hopkins Bloomberg School of Public Health; 
February 2019; Baltimore, MD. 
• L. Wang, I. Coppens. Investigating the Dynamics of the Interaction between 
Mammalian Host Organelles and Toxoplasma. Presented to MMI Departmental 
Research Forum at Johns Hopkins Bloomberg School of Public Health; April 2018; 
Baltimore, MD. 
• L. Wang, J. Humphries. Molecular characterization and immune responses of 
macrophage expressed gene from freshwater snail, Biomphalaria glabrata. Poster 
session presented at Senior Experience Symposium at Lawrence University; May 2017; 
Appleton, WI. 
• L. Wang, M. R. Schnorenberg, J. LaBelle. Cloning of CD19 single chain variable 
fragment (scFv) for a new peptide-based therapeutic delivery system. Poster session 
presented at Summer Research Symposium at Lawrence University; Oct 2016; 
Appleton, WI. 
 
OTHER WORK EXPERIENCES 
• Immunology Content Tutor, Center for Academic Success          Jan 2017-Mar 2017 
Lawrence University, Appleton, WI    
• Student Assistant, Biological Stock Room                                     Nov 2016-Jan 2017 
Lawrence University, Appleton, WI    
• Chinese Content Tutor, Center for Academic Success                Sept 2014-June 2017 
Lawrence University, Appleton, WI    
 
VOLUNTEER EXPERIENCES:  
• Shelter volunteer, Saving Paws Animal Rescue In.,                      Sept 2013-Jun 2017 
• English Tutor, Fox Valley Literacy Council,                             Sept 2014-Jun 2016 
• Volunteer, St. Elizabeth Hospital,                                         Sept 2014-Jun 2015 
 
LEADERSHIPS: 
• Publicity Chair, People for Animal Welfare, Appleton, WI          Sept 2015-Jun 2017 
• Secretory, Chinese Student Association, Appleton, WI                 Sept 2015-Jun 2016 
 
 
